Mary K. Crow, MD, and Jane E. Salmon, MD, Named Honorary Members of the European League Against Rheumatism

Mary K. Crow, MD, physician-in-chief and chief of Rheumatology, and Jane E. Salmon, MD, rheumatologist at Hospital for Special Surgery (HSS), have been named honorary members of the European League Against Rheumatism (EULAR) during the Annual European Congress of Rheumatology in Amsterdam.

Founded in 1947, EULAR’s mission is to reduce the burden of rheumatic conditions and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases. EULAR represents the scientific societies of rheumatology in all the European nations, health professional associations, and organizations for people with rheumatism.

As a mark of distinction, EULAR elects honorary members based on their outstanding service in accomplishing the organization’s objectives and in 2017, began nominating its first overseas individuals. Dr. Crow is among the first two Americans honored in 2017, and Dr. Salmon is the third American recognized.

About Dr. Crow

As physician-in-chief and chief of Rheumatology, Dr. Crow leads 66 full-time physicians including both adult and pediatric rheumatologists. Additionally, Dr. Crow’s academic and research career has focused on the molecular mechanisms that underlie systemic autoimmune diseases with a focus systemic lupus erythematosus and rheumatoid arthritis.

About Dr. Salmon

At HSS, Dr. Salmon is the director of the Lupus and APS Center of Excellence, co-director of the Mary Kirkland Center for Lupus Research, and director of the FOCIS Center of Excellence. Dr. Salmon’s research has focused on the mechanisms of tissue injury in lupus and other autoimmune conditions.

About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients from 80 countries and performed more than 32,000 surgical procedures. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Innovation Institute was formed in 2015 to realize the potential of new drugs, therapeutics and devices; the global standard total knee replacement was developed at HSS in 1969, and in 2017 HSS made 130 invention submissions (more than 2x the submissions in 2015). The HSS Education Institute provides continuing medical curriculum to more than 22,000 subscribing musculoskeletal healthcare professionals in 125 countries. Through HSS Global, the institution is collaborating with medical centers worldwide to advance the quality and value of care and to make world-class HSS care more accessible to more people.